Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
55.4
64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Cash & Cash Equivalents
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cash & Cash Equivalents
ď·Ľ214.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cash & Cash Equivalents
ď·Ľ143m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cash & Cash Equivalents
ď·Ľ379.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
31%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cash & Cash Equivalents
ď·Ľ170.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Cash & Cash Equivalents
ď·Ľ350m
|
CAGR 3-Years
60%
|
CAGR 5-Years
53%
|
CAGR 10-Years
26%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cash & Cash Equivalents
ď·Ľ537.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is a SA-based company operating in Health Care Providers & Services industry. The company is headquartered in Jeddah, Makkah. The company went IPO on 2024-06-05. Dr. Soliman Fakeeh Hospital (DSFH) is a Saudi Arabia-based company. The firm is engaged in operating private hospitals and clinics. The company offers its medical services through six units: the Specialty Units, which include burn care unit, renal dialysis unit, extended care unit, In vitro fertilization lab, extra corporeal shock wave lithotripsy (ESWL Unit), hyperbaric oxygen unit, bone marrow transplant unit, organ transplantation center, allergy, immunology and respiratory and sleep disorders unit (AIRS Unit); Laboratory Unit, which includes pathology section, hematological diagnosis laboratory, toxicology and drug monitoring laboratory, microbiology laboratory and virology laboratory; Executive Health Program, which is a personalized health Program, offering a range of consultations, investigations and diagnostic procedures; Clinical Department, which includes internal medicine, obstetrics & gynecology, pediatrics, general surgery and anesthesia, among others; Pharmacy, and Radiology.
See Also
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash & Cash Equivalents?
Cash & Cash Equivalents
214.3m
SAR
Based on the financial report for Dec 31, 2023, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash & Cash Equivalents amounts to 214.3m SAR.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 1Y
-32%
Over the last year, the Cash & Cash Equivalents growth was -32%.
You don't have any saved screeners yet
